Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir

被引:0
|
作者
Danielle Perez-Bercoff
Perrine Triqueneaux
Christine Lambert
Aboubacar Alassane Oumar
Anne-Marie Ternes
Sounkalo Dao
Patrick Goubau
Jean-Claude Schmit
Jean Ruelle
机构
[1] CRP-Santé,Laboratoire de Rétrovirologie
[2] AIDS Reference Laboratory,UCLouvain
[3] de Pharmacie et d'Odontostomatologie de Bamako,Faculté de Médecine
[4] International center of Excellence Research Mali (ICER-Mali),undefined
来源
关键词
Human Immunodeficiency Virus Type; Raltegravir; Replicative Capacity; Elvitegravir; I175M Mutation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir
    Bercoff, Danielle Perez
    Triqueneaux, Perrine
    Lambert, Christine
    Oumar, Aboubacar Alassane
    Ternes, Anne-Marie
    Dao, Sounkalo
    Goubau, Patrick
    Schmit, Jean-Claude
    Ruelle, Jean
    RETROVIROLOGY, 2010, 7
  • [2] Hot Spots of Integrase Genotypic Changes Leading to HIV-2 Resistance to Raltegravir
    Charpentier, Charlotte
    Roquebert, Benedicte
    Delelis, Olivier
    Larrouy, Lucile
    Matheron, Sophie
    Tubiana, Roland
    Karmochkine, Marina
    Duval, Xavier
    Chene, Genevieve
    Storto, Alexandre
    Collin, Gilles
    Benard, Antoine
    Damond, Florence
    Mouscadet, Jean-Francois
    Brun-Vezinet, Francoise
    Descamps, Diane
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (03) : 1293 - 1295
  • [3] HIV-2 Integrase Polymorphisms and Longitudinal Genotypic Analysis of HIV-2 Infected Patients Failing a Raltegravir-Containing Regimen
    Cavaco-Silva, Joana
    Abecasis, Ana
    Miranda, Ana Claudia
    Pocas, Jose
    Narciso, Jorge
    Aguas, Maria Joao
    Maltez, Fernando
    Almeida, Isabel
    Germano, Isabel
    Diniz, Antonio
    de Fatima Goncalves, Maria
    Gomes, Perpetua
    Cunha, Celso
    Camacho, Ricardo Jorge
    PLOS ONE, 2014, 9 (03):
  • [4] Polymorphism of HIV-2 integrase gene and in vitro phenotypic susceptibility of HIV-2 clinical isolates to integrase inhibitors:: raltegravir and evitegravir
    Roquebert, B.
    Damond, F.
    Collin, G.
    Matheron, S.
    Taieb, A.
    Peytavin, Ct
    Benard, A.
    Campa, P.
    Chene, G.
    Brun-Vezinet, F.
    Descamps, D.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S92 - S92
  • [5] Polymorphism of HIV-2 integrase gene and in vitro phenotypic susceptibility of HIV-2 clinical isolates to integrase inhibitors:: raltegravir and evitegravir
    Roquebert, B.
    Damond, F.
    Collin, G.
    Matheron, S.
    Taieb, A.
    Peytavin, G.
    Bernard, A.
    Campa, P.
    Chene, G.
    Brun-Vezinet, F.
    Descamp, D.
    ANTIVIRAL THERAPY, 2007, 12 : S92 - S92
  • [6] HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro
    Roquebert, B.
    Damond, F.
    Collin, G.
    Matheron, S.
    Peytavin, G.
    Benard, A.
    Campa, P.
    Chene, G.
    Brun-Vezinet, F.
    Descamps, D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 914 - 920
  • [8] Phenotypic susceptibility of HIV-2 to raltegravir: integrase mutations Q148R and N155H confer raltegravir resistance
    Smith, Robert A.
    Raugi, Dana N.
    Kiviat, Nancy B.
    Hawes, Stephen E.
    Mullins, James I.
    Sow, Papa S.
    Gottlieb, Geoffrey S.
    AIDS, 2011, 25 (18) : 2235 - 2241
  • [9] Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity
    Salgado, Maria
    Toro, Carlos
    Simon, Ainhoa
    Garrido, Carolina
    Blanco, Francisco
    Soriano, Vincent
    Rodes, Berta
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 (02) : 173 - 175
  • [10] Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
    Requena, Silvia
    Trevino, Ana
    Cabezas, Teresa
    Garcia-Delgado, Rosa
    Jose Amengual, Maria
    Belen Lozano, Ana
    Penaranda, Maria
    Manuel Fernandez, Juan
    Soriano, Vicente
    de Mendoza, Carmen
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (07) : 2083 - 2088